title: Inhibition of a novel model of murine experimental autoimmune orchitis by intravenous administration with a soluble testicular antigen: participation of CD8+ regulatory T cells.
abstract: Recently, we established a novel murine model of experimental autoimmune orchitis (EAO) in C3H/He mice by means of two sc injections of 1 x 10(7) viable syngeneic testicular germ cells (TC) without the use of any adjuvants. Using this model, an effective and reproducible system of immunoregulation in EAO was developed. The induction of this EAO was suppressed by pretreatment with five iv injections of a soluble (deaggregated) form of murine testicular antigen (mTA). The antigen, mTA, was prepared by acid extraction and ammonium sulfate precipitation of defatted testes and epididymides. The development of EAO and relevant delayed-type hypersensitivity was suppressed in an antigen-specific fashion, but anti-TC antibody formation was not affected. A single dose of cyclophosphamide at 2 days after the tolerogenic regime abrogated the unresponsiveness to EAO. Three doses of recombinant interleukin 2 at every other day starting on the next day of the last pretreatment did not overcome the unresponsiveness to EAO. CD8+ T cells isolated from the spleen of deaggregated mTA-pretreated animals could adoptively transfer suppression against EAO into naive recipients, whereas CD4+ T cells failed to transfer the suppression.
authors.affiliation: Department of Immunology and Immunopathology, Kagawa Medical School, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Mukasa
authors.forename: M
authors.initials: M
authors.lastname: Itoh
authors.forename: Y
authors.initials: Y
authors.lastname: Tokunaga
authors.forename: C
authors.initials: C
authors.lastname: Hiramine
authors.forename: K
authors.initials: K
authors.lastname: Hojo
mesh_terms: D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D001327:Autoimmune Diseases / Q000150:complications* / Q000517:prevention & control; D016827:CD8 Antigens / Q000032:analysis*; D003520:Cyclophosphamide / Q000494:pharmacology; D007111:Immunity, Cellular; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000494:pharmacology; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D009920:Orchitis / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D013737:Testis / Q000276:immunology
chemical_list: D000941:Antigens; D016827:CD8 Antigens; D007376:Interleukin-2; D003520:Cyclophosphamide